TABLE 3.
Outcomes during follow‐up
Death | 24 (24.0%) |
COVID‐19 (respiratory failure) | 15 (15.0%) |
PE | 5 (5.0%) |
Bleeding | 2 (2.0%) |
Cancer | 1 (1.0%) |
Unknown | 1 (1.0%) |
VTE recurrence | 0 (0.0%) |
Bleeding | 20 (20.0%) |
Major bleeding | 11 (11.0%) |
Location of bleeding (n = 20) | |
Hematoma | 4 (4.0%) |
Cerebral | 3 (3.0%) |
Retroperitoneal | 3 (3.0%) |
Muscular | 2 (2.0%) |
Urinary | 2 (2.0%) |
Gastrointestinal | 1 (1.0%) |
Other | 5 (4.0%) |
Abbreviations: PE, pulmonary embolism; VTE, venous thromboembolism.